Skip to content

Verification Study and Reactivity Study for the Validity of QuQu Scale

Verification Study and Reactivity Study for the Validity of a Novel Dementia Rating Scale QUick QUestion Scale for Alzheimer's Disease Dementia

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02667665
Acronym
QuQu
Enrollment
240
Registered
2016-01-29
Start date
2016-02-19
Completion date
2016-11-15
Last updated
2017-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer's Disease Dementia, Cognitive Concern Without Dementia

Keywords

Alzheimer's Disease Dementia

Brief summary

Examine the construct validity, the test-retest reliability, the concurrent validity with the standard dementia rating scales and the reactivity of a novel dementia rating scale QuQu scale: QUick QUestion scale final for the evaluation of patients with Alzheimer's Disease Dementia and Mild Cognitive Impairment.

Interventions

None listed

Sponsors

Daiichi Sankyo Co., Ltd.
CollaboratorINDUSTRY
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

1. Alzheimer's Disease Dementia and patients with cognitive concern without Dementia 2. Written Informed consent by each subject and/or a legal representative, and study informant. If the doctor decides that the patient has no trouble in understanding this study, the written informed consent of a legal representative may be exempted. If not, this study needs a written informed consent by a legal representative and the patient except the case where the consent is hardly obtained due to the progression of the disease.

Exclusion criteria

1. patients with other types of dementia (e.g. vascular dementia, Levy body dementia, frontotemporal dementia) 2. patients with other diseases which cause secondary dementia prior to Alzheimer's Disease Dementia 3. patients with other severe neurological disease or psychiatric disorder without Alzheimer's Disease Dementia 4. patients with other medical conditions where the investigators determine that it is inappropriate for the subject of this study (e.g. inappropriate for the evaluation of dementia rating scale)

Design outcomes

Primary

MeasureTime frame
QuQu scale candidate12 weeks
Mini-Mental State Examination (MMSE)12 weeks
NPI-Caregiver Distress. Scale(NPI-D)12 weeks
Disability Assessment for Dementia (DAD)12 weeks
Clinical Dementia Rating12 weeks

Countries

Japan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026